Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Alere Inc opts not to pursue initial public offering by BBI Diagnostics Group plc


Wednesday, 18 Jun 2014 11:30am EDT 

Alere Inc:Elects not to proceed at this time with its previously announced plans to pursue an initial public offering in the United Kingdom of the ordinary shares of BBI Diagnostics Group plc, or BBI Diagnostics.Intends to seek greater value for businesses of BBI Diagnostics than could be realized under current equity market conditions in the United Kingdom.Alere remains committed to its previously communicated strategy of divesting of non-core assets and to the use of proceeds from such divestitures to reduce its outstanding indebtedness. 

Company Quote

39.97
-0.21 -0.52%
2:59pm EST